Cerus (CERS) Shares Outstanding (Weighted Average) (2010 - 2026)

Cerus' (CERS) quarterly Shares Outstanding (Weighted Average) came in at $194.1 million in Q1 2026, up 3.78% year-on-year from $187.1 million in Q1 2025, and up 1.86% quarter-over-quarter from $190.6 million in Q4 2025.

Cerus (CERS) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Cerus has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $194.1 million for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $194.1 million, up 3.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $194.1 million (up 3.78% YoY), and the FY2025 annual result was $190.6 million, up 3.27% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $194.1 million for Q1 2026 at Cerus, up from $190.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $194.1 million in Q1 2026 to a low of $174.5 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $182.1 million (2024), against an average of $183.0 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) grew 2.11% in 2023 and climbed 4.23% in 2025, its largest moves.
  • Cerus' Shares Outstanding (Weighted Average) stood at $176.5 million in 2022, then gained by 2.11% to $180.3 million in 2023, then gained by 2.38% to $184.6 million in 2024, then gained by 3.27% to $190.6 million in 2025, then advanced by 1.86% to $194.1 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $194.1 million (Q1 2026), $190.6 million (Q4 2025), and $191.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.74 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 382.90 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 579.20 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 456.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 385.10 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 98.20 Mn
10 Cerus 496.03 Mn 416.34 Mn 27.89 Mn 194.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 194.14 Mn
Dec 31, 2025 190.59 Mn
Sep 30, 2025 191.83 Mn
Jun 30, 2025 191.30 Mn
Mar 31, 2025 187.07 Mn
Dec 31, 2024 184.56 Mn
Sep 30, 2024 184.17 Mn
Jun 30, 2024 183.54 Mn
Mar 31, 2024 182.09 Mn
Dec 31, 2023 180.27 Mn
Sep 30, 2023 179.95 Mn
Jun 30, 2023 179.45 Mn
Mar 31, 2023 178.27 Mn
Dec 31, 2022 176.55 Mn
Sep 30, 2022 176.23 Mn
Jun 30, 2022 175.72 Mn
Mar 31, 2022 174.48 Mn
Dec 31, 2021 171.28 Mn
Sep 30, 2021 170.67 Mn
Jun 30, 2021 170.04 Mn